Pluri Inc. Payments for (Proceeds from) Short-term Investments
Pluri Inc. (PLUR) reported Payments for (Proceeds from) Short-term Investments of -$10.52 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromShortTermInvestments · last filed 2026-09-10
- Pluri Inc. payments for (proceeds from) short-term investments for the quarter ending 2026-06-30 was -$1.62M.
- Pluri Inc. payments for (proceeds from) short-term investments for the quarter ending 2026-03-31 was -$1.83M, a 150.07% decline year-over-year.
- Pluri Inc. payments for (proceeds from) short-term investments for the quarter ending 2025-12-31 was -$3.10M.
- Pluri Inc. payments for (proceeds from) short-term investments for the quarter ending 2025-09-30 was -$3.97M.
- Pluri Inc. payments for (proceeds from) short-term investments for fiscal 2026 was -$10.52M.
- Pluri Inc. payments for (proceeds from) short-term investments for fiscal 2025 was -$9.27M.
- Pluri Inc. payments for (proceeds from) short-term investments for fiscal 2024 was -$10.91M.
- Pluri Inc. payments for (proceeds from) short-term investments for fiscal 2023 was -$9.96M.
| Period end | Payments for (Proceeds from) Short-term Investments 3 month | Payments for (Proceeds from) Short-term Investments 3 month as first filed | Payments for (Proceeds from) Short-term Investments 6 month | Payments for (Proceeds from) Short-term Investments 6 month as first filed | Payments for (Proceeds from) Short-term Investments 9 month | Payments for (Proceeds from) Short-term Investments 9 month as first filed | Payments for (Proceeds from) Short-term Investments 12 month | Payments for (Proceeds from) Short-term Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$3.45M derived: sum of 2 quarters · filed 2026-09-10 | -$6.55M derived: sum of 3 quarters · filed 2026-09-10 | -$10.52M 10-K · filed 2026-09-10 | ||||
| 2026-03-31 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$4.93M derived: sum of 2 quarters · filed 2026-05-14 | -$8.90M 10-Q · filed 2026-05-14 | -$12.28M derived: sum of 4 quarters · filed 2026-09-10 | ||||
| 2025-12-31 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$7.07M 10-Q · filed 2026-02-12 | -$10.45M derived: sum of 3 quarters · filed 2026-09-10 | -$6.79M derived: sum of 4 quarters · filed 2026-09-10 | ||||
| 2025-09-30 | -$3.97M 10-Q · filed 2025-11-12 | -$7.34M derived: sum of 2 quarters · filed 2026-09-10 | -$3.69M derived: sum of 3 quarters · filed 2026-09-10 | -$12.44M derived: sum of 4 quarters · filed 2026-09-10 | ||||
| 2025-06-30 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $279.00K derived: sum of 2 quarters · filed 2026-09-10 | -$8.48M derived: sum of 3 quarters · filed 2026-09-10 | -$9.27M 10-K · filed 2026-09-10 | ||||
| 2025-03-31 | $3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$5.10M derived: sum of 2 quarters · filed 2026-05-14 | -$5.89M 10-Q · filed 2026-05-14 | -$1.10M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$8.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$9.55M 10-Q · filed 2026-02-12 | -$4.75M derived: sum of 3 quarters · filed 2026-02-12 | -$10.51M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-09-30 | -$793.00K 10-Q · filed 2025-11-12 | $4.00M derived: sum of 2 quarters · filed 2025-11-12 | -$1.75M derived: sum of 3 quarters · filed 2025-11-12 | -$5.79M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | -$962.00K derived: sum of 2 quarters · filed 2025-09-17 | -$5.00M derived: sum of 3 quarters · filed 2025-09-17 | -$10.91M 10-K · filed 2025-09-17 | ||||
| 2024-03-31 | -$5.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$9.80M derived: sum of 2 quarters · filed 2025-05-13 | -$15.70M 10-Q · filed 2025-05-13 | -$20.12M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | -$9.95M 10-Q · filed 2025-02-11 | -$10.01M 10-Q · filed 2024-02-12 | -$14.37M derived: sum of 3 quarters · filed 2025-02-11 | -$12.70M derived: sum of 4 quarters · filed 2025-02-11 | |||
| 2023-09-30 | -$5.91M 10-Q · filed 2024-11-12 | -$10.33M derived: sum of 2 quarters · filed 2024-11-12 | -$8.66M derived: sum of 3 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | -$4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | -$2.76M derived: sum of 2 quarters · filed 2024-09-18 | -$9.96M 10-K · filed 2024-09-18 | |||||
| 2023-03-31 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-09 | -$5.54M 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | -$7.20M 10-Q · filed 2024-02-12 | |||||||
| 2020-06-30 | $29.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $28.73M derived: sum of 2 quarters · filed 2020-09-10 | $22.75M derived: sum of 3 quarters · filed 2020-09-10 | $17.95M 10-K · filed 2020-09-10 | ||||
| 2020-03-31 | -$704.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | -$6.69M derived: sum of 2 quarters · filed 2020-05-11 | -$11.49M 10-Q · filed 2020-05-11 | $7.00M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2019-12-31 | -$5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | -$10.79M 10-Q · filed 2020-02-06 | $7.71M derived: sum of 3 quarters · filed 2020-09-10 | $908.00K derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2019-09-30 | -$4.80M 10-Q · filed 2019-11-07 | $13.69M derived: sum of 2 quarters · filed 2020-09-10 | $6.89M derived: sum of 3 quarters · filed 2020-09-10 | $1.58M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2019-06-30 | $18.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $11.69M derived: sum of 2 quarters · filed 2020-09-10 | $6.39M derived: sum of 3 quarters · filed 2020-09-10 | -$1.42M 10-K · filed 2020-09-10 | ||||
| 2019-03-31 | -$6.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | -$12.11M derived: sum of 2 quarters · filed 2020-05-11 | -$19.91M 10-Q · filed 2020-05-11 | -$25.51M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2018-12-31 | -$5.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | -$13.11M 10-Q · filed 2020-02-06 | -$18.71M derived: sum of 3 quarters · filed 2020-09-10 | -$8.10M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2018-09-30 | -$7.80M 10-Q · filed 2019-11-07 | -$13.40M derived: sum of 2 quarters · filed 2020-09-10 | -$2.79M derived: sum of 3 quarters · filed 2020-09-10 | $10.96M derived: sum of 4 quarters · filed 2020-09-10 | ||||
| 2018-06-30 | -$5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $5.01M derived: sum of 2 quarters · filed 2020-09-10 | $18.76M derived: sum of 3 quarters · filed 2020-09-10 | $14.72M 10-K · filed 2020-09-10 | $14.83M 10-K · filed 2018-09-12 | |||
| 2018-03-31 | $10.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | $24.36M derived: sum of 2 quarters · filed 2019-05-06 | $20.32M 10-Q · filed 2019-05-06 | $21.01M 10-Q · filed 2018-05-09 | $14.16M derived: sum of 4 quarters · filed 2019-09-12 | |||
| 2017-12-31 | $13.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $9.71M 10-Q · filed 2019-02-06 | $9.72M 10-Q · filed 2018-02-06 | $3.55M derived: sum of 3 quarters · filed 2019-09-12 | $15.88M derived: sum of 4 quarters · filed 2019-09-12 | |||
| 2017-09-30 | -$4.04M 10-Q · filed 2018-11-07 | -$4.00M 10-Q · filed 2017-11-07 | -$10.21M derived: sum of 2 quarters · filed 2019-09-12 | $2.13M derived: sum of 3 quarters · filed 2019-09-12 | -$4.58M derived: sum of 4 quarters · filed 2019-09-12 | |||
| 2017-06-30 | -$6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $6.17M derived: sum of 2 quarters · filed 2019-09-12 | -$539.00K derived: sum of 3 quarters · filed 2019-09-12 | -$2.37M 10-K · filed 2019-09-12 | -$2.32M 10-K · filed 2017-09-07 | |||
| 2017-03-31 | $12.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $5.63M derived: sum of 2 quarters · filed 2018-05-09 | $3.79M 10-Q · filed 2018-05-09 | $1.12M derived: sum of 4 quarters · filed 2018-09-12 | ||||
| 2016-12-31 | -$6.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | -$8.54M 10-Q · filed 2018-02-06 | -$11.22M derived: sum of 3 quarters · filed 2018-09-12 | -$16.49M derived: sum of 4 quarters · filed 2018-09-12 | ||||
| 2016-09-30 | -$1.83M 10-Q · filed 2017-11-07 | -$4.51M derived: sum of 2 quarters · filed 2018-09-12 | -$9.78M derived: sum of 3 quarters · filed 2018-09-12 | -$8.91M derived: sum of 4 quarters · filed 2018-09-12 | ||||
| 2016-06-30 | -$2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | -$7.95M derived: sum of 2 quarters · filed 2018-09-12 | -$7.08M derived: sum of 3 quarters · filed 2018-09-12 | $849.00K 10-K · filed 2018-09-12 | ||||
| 2016-03-31 | -$5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$4.40M derived: sum of 2 quarters · filed 2017-05-08 | $3.52M 10-Q · filed 2017-05-08 | -$26.00K derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-12-31 | $866.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $8.79M 10-Q · filed 2017-02-08 | $5.24M derived: sum of 3 quarters · filed 2017-09-07 | $3.81M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-09-30 | $7.93M 10-Q · filed 2016-11-07 | $4.38M derived: sum of 2 quarters · filed 2017-09-07 | $2.94M derived: sum of 3 quarters · filed 2017-09-07 | -$3.36M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-06-30 | -$3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | -$4.99M derived: sum of 2 quarters · filed 2017-09-07 | -$11.28M derived: sum of 3 quarters · filed 2017-09-07 | -$16.06M 10-K · filed 2017-09-07 | ||||
| 2015-03-31 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | -$7.73M derived: sum of 2 quarters · filed 2016-05-09 | -$12.51M 10-Q · filed 2016-05-09 | -$17.99M derived: sum of 4 quarters · filed 2016-09-07 | ||||
| 2014-12-31 | -$6.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | -$11.07M 10-Q · filed 2016-02-08 | -$16.55M derived: sum of 3 quarters · filed 2016-09-07 | -$10.53M derived: sum of 4 quarters · filed 2016-09-07 | ||||
| 2014-09-30 | -$4.78M 10-Q · filed 2015-11-05 | -$10.25M derived: sum of 2 quarters · filed 2016-09-07 | -$4.24M derived: sum of 3 quarters · filed 2016-09-07 | -$5.07M derived: sum of 4 quarters · filed 2016-09-07 | ||||
| 2014-06-30 | -$5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $540.00K derived: sum of 2 quarters · filed 2016-09-07 | -$289.00K derived: sum of 3 quarters · filed 2016-09-07 | -$7.42M 10-K · filed 2016-09-07 | ||||
| 2014-03-31 | $6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $5.19M derived: sum of 2 quarters · filed 2015-05-06 | -$1.95M 10-Q · filed 2015-05-06 | $6.85M derived: sum of 4 quarters · filed 2015-09-09 | ||||
| 2013-12-31 | -$829.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$7.96M 10-Q · filed 2015-02-05 | $833.00K derived: sum of 3 quarters · filed 2015-09-09 | |||||
| 2013-09-30 | -$7.13M 10-Q · filed 2014-11-06 | $1.66M derived: sum of 2 quarters · filed 2015-09-09 | ||||||
| 2013-06-30 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $10.20M 10-K · filed 2015-09-09 | ||||||
| 2013-03-31 | $1.41M 10-Q · filed 2014-05-08 | |||||||
| 2012-06-30 | $21.03M 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |